文献速递银屑病与炎症性皮肤病

银屑病患者中银屑病关节炎的患病率:观察性与临床研究的系统评价和Meta分析

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies.
PubMed 文献 · J Am Acad Dermatol · 2018-06-19

该系统评价与Meta分析纳入266项研究、976,408例银屑病患者,旨在评估银屑病关节炎的患病率与发病率。银屑病患者中银屑病关节炎的合并比例为19.7%(95%CI,18.5%-20.9%),儿童及青少年(<18岁)为3.3%(95%CI,2.1%-4.9%)。

要点

  • 银屑病患者中银屑病关节炎的合并比例为19.7%(95%CI,18.5%-20.9%)。
  • 儿童及青少年(<18岁)银屑病关节炎的合并患病率为3.3%(95%CI,2.1%-4.9%)。
  • 应用银屑病关节炎分类标准的研究中银屑病关节炎患病率为23.8%(95%CI,20.1%-27.6%)。

核心结论

  • 约1/4的银屑病患者患有银屑病关节炎。
  • 随着银屑病关节炎分类标准被日益认识,有望报告更同质和可比的患病率估计。

研究设计与样本

  • 两位作者独立检索3个数据库,纳入报告银屑病患者中银屑病关节炎患病率或发病率的研究。
  • 共纳入266项研究,涵盖976,408例银屑病患者。
  • 采用比例Meta分析计算银屑病患者中银屑病关节炎的合并比例估计。

主要发现

  • 银屑病患者中银屑病关节炎的合并比例(95%CI)为19.7%(95%CI,18.5%-20.9%)。
  • 儿童及青少年(<18岁)银屑病关节炎的合并患病率为3.3%(95%CI,2.1%-4.9%)。
  • 欧洲银屑病患者银屑病关节炎患病率为22.7%(95%CI,20.6%-25.0%),南美为21.5%(95%CI,15.4%-28.2%),北美为19.5%(95%CI,17.1%-22.1%),非洲为15.5%(95%CI,0.009%-51.5%),亚洲为14.0%(95%CI,11.7%-16.3%)。
  • 应用银屑病关节炎分类标准的研究中银屑病关节炎患病率为23.8%(95%CI,20.1%-27.6%)。
  • 银屑病患者中银屑病关节炎的发病率为0.27至2.7/100人年。

局限性

  • 研究间异质性可能影响了估计值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Wide-ranging prevalence estimates of psoriatic arthritis (PsA) in patients with psoriasis have been reported. OBJECTIVES: To assess the prevalence and incidence of PsA in patients with psoriasis. METHODS: Two authors independently searched 3 databases for studies reporting on the prevalence or incidence of PsA in patients with psoriasis. A proportion meta-analysis was performed to calculate the pooled proportion estimates of PsA in patients with psoriasis. RESULTS: A total of 266 studies examining 976,408 patients with psoriasis were included. Overall, the pooled proportion (95% confidence interval [CI]) of PsA among patients with psoriasis was 19.7% (95% CI, 18.5%-20.9%). In children and adolescents (<18 years of age), the pooled prevalence was 3.3% (95% CI, 2.1%-4.9%). The PsA prevalence was 22.7% (95% CI, 20.6%-25.0%) in European patients with psoriasis, 21.5% (95% CI, 15.4%-28.2%) in South American patients with psoriasis, 19.5% (95% CI, 17.1%-22.1%) in North American patients with psoriasis, 15.5% (95% CI, 0.009%-51.5%) in African patients with psoriasis, and 14.0% (95% CI, 95% CI, 11.7%-16.3%) in Asian patients with psoriasis. The prevalence of PsA was 23.8% (95% CI, 20.1%-27.6%) in studies in which the Classification Criteria for Psoriatic Arthritis were applied. The incidence of PsA among patients with psoriasis ranged from 0.27 to 2.7 per 100 person-years. LIMITATIONS: Between-study heterogeneity may have affected the estimates. CONCLUSIONS: We found that 1 in 4 patients with psoriasis have PsA. With the growing recognition of the Classification Criteria for Psoriatic Arthritis, more homogenous and comparable prevalence estimates are expected to be reported.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Alinaghi F, Calov M, Kristensen LE, et al. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2018. PMID: 29928910. doi:10.1016/j.jaad.2018.06.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。